vs
Side-by-side financial comparison of Nuvation Bio Inc. (NUVB) and READING INTERNATIONAL INC (RDI). Click either name above to swap in a different company.
READING INTERNATIONAL INC is the larger business by last-quarter revenue ($50.3M vs $41.9M, roughly 1.2× Nuvation Bio Inc.). On growth, Nuvation Bio Inc. posted the faster year-over-year revenue change (633.1% vs -14.2%).
Nuvation Bio Inc. is a clinical-stage biopharmaceutical company focused on researching and developing targeted oncology therapies to address unmet medical needs in difficult-to-treat cancer types. Its core pipeline features novel drug candidates targeting key oncogenic pathways, with primary operations and market presence centered in North America.
The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.
NUVB vs RDI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $41.9M | $50.3M |
| Net Profit | — | $-2.6M |
| Gross Margin | — | — |
| Operating Margin | -81.3% | -1.9% |
| Net Margin | — | -5.1% |
| Revenue YoY | 633.1% | -14.2% |
| Net Profit YoY | — | -14.5% |
| EPS (diluted) | $-0.11 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $41.9M | $50.3M | ||
| Q3 25 | $13.1M | $52.2M | ||
| Q2 25 | — | $60.4M | ||
| Q1 25 | — | $40.2M | ||
| Q4 24 | $5.7M | $58.6M | ||
| Q3 24 | — | $60.1M | ||
| Q2 24 | — | $46.8M | ||
| Q1 24 | $0 | $45.1M |
| Q4 25 | — | $-2.6M | ||
| Q3 25 | $-55.8M | $-4.2M | ||
| Q2 25 | — | $-2.7M | ||
| Q1 25 | — | $-4.8M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | — | $-7.0M | ||
| Q2 24 | — | $-12.8M | ||
| Q1 24 | $-14.8M | $-13.2M |
| Q4 25 | — | — | ||
| Q3 25 | 74.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 26.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -81.3% | -1.9% | ||
| Q3 25 | -430.1% | -0.6% | ||
| Q2 25 | — | 4.8% | ||
| Q1 25 | — | -17.2% | ||
| Q4 24 | -944.5% | 2.6% | ||
| Q3 24 | — | -0.6% | ||
| Q2 24 | — | -16.4% | ||
| Q1 24 | — | -16.7% |
| Q4 25 | — | -5.1% | ||
| Q3 25 | -425.2% | -8.0% | ||
| Q2 25 | — | -4.4% | ||
| Q1 25 | — | -11.8% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | — | -11.7% | ||
| Q2 24 | — | -27.4% | ||
| Q1 24 | — | -29.4% |
| Q4 25 | $-0.11 | $-0.11 | ||
| Q3 25 | $-0.16 | $-0.18 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | — | $-0.21 | ||
| Q4 24 | $0.00 | $-0.11 | ||
| Q3 24 | — | $-0.31 | ||
| Q2 24 | — | $-0.57 | ||
| Q1 24 | $-0.07 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $529.2M | $10.5M |
| Total DebtLower is stronger | $47.2M | $185.1M |
| Stockholders' EquityBook value | $305.7M | $-18.2M |
| Total Assets | $594.8M | $434.9M |
| Debt / EquityLower = less leverage | 0.15× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $529.2M | $10.5M | ||
| Q3 25 | $549.0M | $8.1M | ||
| Q2 25 | — | $9.1M | ||
| Q1 25 | — | $5.9M | ||
| Q4 24 | $502.7M | $12.4M | ||
| Q3 24 | — | $10.1M | ||
| Q2 24 | — | $9.3M | ||
| Q1 24 | $597.0M | $7.5M |
| Q4 25 | $47.2M | $185.1M | ||
| Q3 25 | $47.1M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $305.7M | $-18.2M | ||
| Q3 25 | $325.9M | $-12.1M | ||
| Q2 25 | — | $-7.7M | ||
| Q1 25 | — | $-8.1M | ||
| Q4 24 | $463.8M | $-4.4M | ||
| Q3 24 | — | $1.6M | ||
| Q2 24 | — | $6.5M | ||
| Q1 24 | $594.0M | $18.0M |
| Q4 25 | $594.8M | $434.9M | ||
| Q3 25 | $601.6M | $435.2M | ||
| Q2 25 | — | $438.1M | ||
| Q1 25 | — | $441.0M | ||
| Q4 24 | $540.6M | $471.0M | ||
| Q3 24 | — | $495.7M | ||
| Q2 24 | — | $494.9M | ||
| Q1 24 | $613.1M | $494.9M |
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-29.7M | $4.3M |
| Free Cash FlowOCF − Capex | — | $4.1M |
| FCF MarginFCF / Revenue | — | 8.2% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-2.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-29.7M | $4.3M | ||
| Q3 25 | $-52.9M | $295.0K | ||
| Q2 25 | — | $1.6M | ||
| Q1 25 | — | $-7.7M | ||
| Q4 24 | $-46.3M | $8.0M | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | — | $-10.4M | ||
| Q1 24 | $-15.7M | $-2.8M |
| Q4 25 | — | $4.1M | ||
| Q3 25 | — | $-246.0K | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $-8.0M | ||
| Q4 24 | — | $7.0M | ||
| Q3 24 | — | $-1.1M | ||
| Q2 24 | — | $-10.6M | ||
| Q1 24 | — | $-4.7M |
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | -0.5% | ||
| Q2 25 | — | 1.9% | ||
| Q1 25 | — | -19.8% | ||
| Q4 24 | — | 12.0% | ||
| Q3 24 | — | -1.8% | ||
| Q2 24 | — | -22.7% | ||
| Q1 24 | — | -10.4% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 4.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUVB
Segment breakdown not available.
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
